ROBIN HOGENMILLER: Open Payments
NPI 1679097653 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$72 in 4 payments from 4 companies in 2025. Trend: 2023 $162 · 2024 $43 · 2025 $72
Food & beverage: $72
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $21 |
| Verona Pharma, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: DALVANCE, Ohtuvayre, JARDIANCE, TRELEGY ELLIPTA.
Industry payments across MD — which companies pay providers there.
